Unlock Full Company Report

Access verified contacts, investors & buying signals.

Get Access
Recently Funded|Amount: EUR 500.0K|Industry: Hospitals and Health Care

Monsana Closes $500K Pre-Seed Round for AI Assistant

Monsana

Monsana Logo
N/A
2-10 employees employees (Est.)
Visit Website
View Full Report

Includes contacts, investors & buying signals

Monsana, a company developing an AI assistant designed to optimize clinical trial processes, has successfully raised $500,000 in a recent funding round from investors. This capital infusion represents a pivotal moment for the firm, which is dedicated to streamlining life sciences research by alleviating the administrative burden on medical professionals. Monsana's innovative technology focuses on lifting brain-draining tasks off doctors and nurses, thereby enhancing efficiency and accelerating the overall research timeline. The secured investment underscores a strong vote of confidence in Monsana's vision and its potential to significantly impact the efficiency of clinical trial operations. The company's AI assistant directly addresses a critical need within the life sciences sector: enabling healthcare professionals to dedicate more time to critical patient care and complex research analyses, rather than routine administrative duties. This strategic funding is expected to empower Monsana to scale its operations and advance its intelligent automation solutions that expedite the path to new medical discoveries. Monsana plans to strategically deploy the newly acquired funds to fuel its ambitious growth initiatives. A primary focus will be on the continued enhancement and expansion of its core AI platform, ensuring its capabilities remain robust and cutting-edge. Furthermore, the investment will support the expansion of its engineering, product development, and customer success teams, which are crucial for evolving the technology and extending its market presence within the clinical research landscape. The company aims to solidify its position as a key enabler for more agile and effective clinical trials. This funding round is anticipated to significantly bolster Monsana’s overarching mission: fostering smarter trials, cultivating happier and more productive research teams, and ultimately contributing to healthier patient outcomes globally. With this strategic capital, Monsana is well-positioned to broaden its impact across the life sciences industry, driving innovation in how life-saving research is conducted and brought to fruition more rapidly and efficiently.
September 23, 2025

Buying Signals & Intent

Our AI suggests Monsana may be interested in solutions related to:

  • Clinical trial management
  • Patient recruitment services
  • AI solutions for healthcare
  • Healthcare analytics
  • Life science partnerships

Sell these products?

Unlock full report to find contacts.

Get Access Now

Investors

Unlock Investor Data

See who invested in Monsana and potentially find related investment contacts.

Unlock Premium Access

Key Decision Makers

Unlock Verified Contacts

Get direct email addresses and phone numbers for key decision makers at Monsana.

Unlock Contacts Now